Cumberland Pharmaceuticals Inc
CPIX- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001087294
No open-market purchases or sales by Cumberland Pharmaceuticals Inc insiders were filed in the last 90 days; 32 institutions reported holding it in 13F filings for Q2 2026, worth $16.0M in total; no superinvestor holds it.
Q2 2025 vs. Q1 2025
How the institutions holding Cumberland Pharmaceuticals Inc changed between Q1 2025 and Q2 2025.
All holders in Q2 2025All holders in Q1 2025
| Measure | Q1 2025 | Q2 2025 | Change |
|---|---|---|---|
| Holders | 33 | 31 | −2 |
| Shares | 4.28M | 3.68M | −598.7K (−14.0%) |
| Value | $18.1M | $12.3M | −$5.82M (−32.0%) |
New holders (6)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q2 2025 but not at the end of Q1 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Heron Bay Capital Management | 33,251 | $111.4K | 0.02% |
| XTX Topco Ltd | 10,280 | $34.4K | 0.00% |
| Group One Trading, L.P. | 8,222 | $27.5K | 0.00% |
| Tower Research Capital LLC (TRC) | 2,102 | $7.04K | 0.00% |
| GWM Advisors LLC | 1,428 | $4.78K | 0.00% |
| Barclays PLC | 2 | $7 | 0.00% |
Sold out (8)
Institutions that held Cumberland Pharmaceuticals Inc at the end of Q1 2025 and filed for Q2 2025 without it.
| Institution | Shares, Q1 2025 | Value, Q1 2025 |
|---|---|---|
| Berkshire Asset Management LLC | 153,810 | $692.1K |
| Adage Capital Partners GP, L.L.C. | 150,000 | $634.5K |
| EAM Investors, LLC | 71,776 | $303.6K |
| Walleye Capital LLC | 70,419 | $297.9K |
| Schonfeld Strategic Advisors LLC | 17,900 | $75.7K |
| Centiva Capital, LP | 1,600 | $6.77K |
| Wells Fargo & Company | 250 | $1.06K |
| JPMorgan Chase & Co | 19 | $80 |